Resultats globals: 3 registres trobats en 0.06 segons.
Articles, 3 registres trobats
Articles 3 registres trobats  
1.
8 p, 1.2 MB Glycemic variability : prognostic impact on acute ischemic stroke and the impact of corrective treatment for hyperglycemia. The GLIAS-III translational study / Fuentes, Blanca (Hospital Universitario La Paz (Madrid)) ; Pastor-Yborra, Silvia (Hospital Universitario La Paz (Madrid)) ; Gutiérrez-Zúñiga, Raquel (Hospital Universitario La Paz (Madrid)) ; González-Pérez de Villar, Noemí (Hospital Universitario La Paz (Madrid)) ; de Celis, Elena (Hospital Universitario La Paz (Madrid)) ; Rodríguez-Pardo, Jorge (Hospital Universitario La Paz (Madrid)) ; Gómez-de Frutos, Mari Carmen (Hospital Universitario La Paz (Madrid)) ; Laso-García, Fernando (Hospital Universitario La Paz (Madrid)) ; Gutiérrez-Fernández, María (Hospital Universitario La Paz (Madrid)) ; Ortega-Casarrubios, MÁngeles (Hospital Universitario 12 de Octubre (Madrid)) ; Soto, Alfonso (Complejo Hospitalario Universitario de A Coruña) ; López-Fernández, María (Complejo Hospitalario Universitario de A Coruña) ; Santamaría, María (Hospital Universitario La Paz (Madrid)) ; Díez-González, Noemí (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Freijo, Mar M. (Instituto de Investigación Sanitaria Biocruces Bizkaia) ; Zandio, Beatriz (Complejo Hospitalario de Navarra) ; Delgado Mederos, Raquel (Institut d'Investigació Biomèdica Sant Pau) ; Calleja, Ana (Hospital Clínico Universitario de Valladolid) ; Portilla-Cuenca, Juan Carlos (Hospital San Pedro de Alcántara) ; Lisbona, Arturo (Hospital Universitario La Paz (Madrid)) ; Otero-Ortega, Laura (Hospital Universitario La Paz (Madrid)) ; Díez-Tejedor, Exuperio (Hospital Universitario La Paz (Madrid)) ; Universitat Autònoma de Barcelona
Glycemic variability (GV) represents the amplitude of oscillations in glucose levels over time and is associated with higher mortality in critically ill patients. Our aim is to evaluate the impact of GV on acute ischemic stroke (IS) outcomes in humans and explore the impact of two different insulin administration routes on GV in an animal model. [...]
2020 - 10.1186/s12967-020-02586-4
Journal of translational medicine, Vol. 18 (november 2020)  
2.
15 p, 1.7 MB Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications / Carrillo-Reixach, Juan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Torrens, L. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Simón-Coma, Marina (Institut Germans Trias i Pujol) ; Royo, Laura (Institut Germans Trias i Pujol) ; Domingo-Sàbat, Montse (Institut Germans Trias i Pujol) ; Abril-Fornaguera, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Akers, N. (Icahn School of Medicine at Mount Sinai (Nova York, Estats Units d'Amèrica)) ; Sala Llinas, Margarita (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ragull, Sonia (Institut Germans Trias i Pujol) ; Arnal, Magdalena (Institut Hospital del Mar d'Investigacions Mèdiques) ; Villalmanzo, Núria (Institut Germans Trias i Pujol) ; Cairo, Stefano (Instituto di Ricerca Pediatrica. Corso Stati Uniti 4) ; Villanueva, Alberto (Institut d'Investigació Biomèdica de Bellvitge) ; Kappler, R. (Department of Pediatric Surgery. Dr. von Hauner Children's Hospital. Ludwig-Maximilians-University Munich) ; Garrido-Pontnou, Marta (Hospital Universitari Vall d'Hebron) ; Guerra, Laura (Hospital Universitario La Paz (Madrid)) ; Sábado, Constantino (Hospital Universitari Vall d'Hebron) ; Guillén, Gabriela (Hospital Universitari Vall d'Hebron) ; Mallo, Maria del Mar (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Piñeyro, David (Institut Germans Trias i Pujol) ; Vázquez-Vitali, María (Institut Germans Trias i Pujol) ; Kuchuk, O. (Mount Sinai Liver Cancer Program. Divisions of Liver Diseases. Tisch Cancer Institute. Icahn School of Medicine at Mount Sinai) ; Mateos, María Elena (Hospital Universitario Reina Sofía (Còrdova, Espanya)) ; Ramírez, G. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Santamaría, María (Hospital Universitario La Paz (Madrid)) ; Mozo, Y. (Hospital Universitario La Paz (Madrid)) ; Soriano, Aroa (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Grotzer, M. (Department of Pediatric Oncology. University Children's Hospital Zurich. University of Zurich) ; Branchereau, S. (Bicêtre Hospital) ; de Andoin, N. G. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; López-Ibor, B. (Department of Pediatric Hematology and Oncology. HM Montepríncipe Hospital) ; López-Almaraz, R. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ; Salinas, J. A. (Hospital Universitari Son Espases (Palma de Mallorca, Balears)) ; Torres, B. (Hospital Universitari i Politècnic La Fe (València)) ; Hernández, Francisco (Hospital Universitario La Paz (Madrid)) ; Uriz, J. J. (Hospital Universitario de Donostia (Sant Sebastià, País Basc)) ; Fabre, M. (Department of Pathology. Hôpital Universitaire Necker-Enfants Malades. Assistance Publique-Hôpitaux de Paris. Université Paris Descartes) ; Blanco, J. (Joan) (Joan) (Universitat de Vic - Universitat Central de Catalunya) ; Paris, C. (Stem Cell Transplant Unit. Hospital Luis Calvo Mackenna) ; Bajčiová, V. (Department of Pediatric Oncology. Childrens University Hospital Brno) ; Laureys, G. (Ghent University Hospital. (Bèlgica)) ; Masnou, Helena (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Clos, Ariadna (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Beléndez, Cristina (Hospital General Universitario Gregorio Marañón) ; Guettier, C. (Bicêtre Hospital) ; Sumoy, Lauro (Institut Germans Trias i Pujol) ; Planas, Ramón (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Jordà, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Nonell, Lara (Institut Hospital del Mar d'Investigacions Mèdiques) ; Czauderna, P. (Department of Surgery and Urology for Children and Adolescents. Medical University of Gdansk) ; Morland, B. (Birmingham Women's Hospital) ; Sia, D. (Mount Sinai Liver Cancer Program. Divisions of Liver Diseases. Tisch Cancer Institute. Icahn School of Medicine at Mount Sinai) ; Losic, B. (Icahn Institute for Data Science and Genomic Technology (Nova York, Estats Units d'Amèrica)) ; Buendia, M. A. (INSERM. UMR 1193. Paul-Brousse Hospital. Hepatobiliary Centre) ; Sarrias, Maria-Rosa (Institut Germans Trias i Pujol) ; Llovet, J. M. (Institució Catalana de Recerca i Estudis Avançats) ; Armengol, Carolina (Institut Germans Trias i Pujol) ; Universitat Autònoma de Barcelona
Background & Aims: Hepatoblastoma (HB) is a rare disease. Nevertheless, it is the predominant pediatric liver cancer, with limited therapeutic options for patients with aggressive tumors. Herein, we aimed to uncover the mechanisms of HB pathobiology and to identify new biomarkers and therapeutic targets in a move towards precision medicine for patients with advanced HB. [...]
2020 - 10.1016/j.jhep.2020.03.025
Journal of Hepatology, Vol. 73 Núm. 2 (august 2020) , p. 328-341  
3.
4 p, 65.5 KB Reseñas / Martínez Santamaría, Ana María
José Luiz de ANDRADE FRANCO ; José Augusto DRUMMOND, Proteção à natureza e identidade nacional no Brasil, anos 1920-1940.
2010
Dynamis : Acta Hispanica ad Medicinae Scientiarumque. Historiam Illustrandam, Vol. 30, Núm. (2010) , p. 343-346  

Vegeu també: autors amb noms similars
1 Santamaria, Montse
1 Santamaría, M.
1 Santamaría, Maite
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.